JUPITER NEUROSCIENCES, INC. (39)

Browse by Contract Category

Contracts

Third Amendment to the Securities Purchase Agreement, dated as of January 13, 2013, between the Company and Puritan Partners LLC (Filed With SEC on January 17, 2023)
Peer Review Summary Statement of FA Grant Application (Filed With SEC on January 6, 2023)
Master Services Agreement, dated as of December 27, 2022, between the Company and Titan Advisory Services (Filed With SEC on January 6, 2023)
License Agreement with Aquanova AG (Filed With SEC on November 9, 2021)
Employment Agreement, dated as of September 1, 2021, between the Company and Christer Rosn (Filed With SEC on October 12, 2021)
Second Amendment to the Securities Purchase Agreement, dated as of November 10, 2022, between the Company and Puritan Partners LLC (Filed With SEC on December 2, 2022)
Amendment to the Securities Purchase Agreement, dated as of October 10, 2022, between the Company and Puritan Partners LLC (Filed With SEC on December 2, 2022)
Research Agreement, dated July 1, 2022, between the Company and University of Miami (Filed With SEC on August 26, 2022)
Form of Strategic Services Agreement (Filed With SEC on August 16, 2022)
Form of Underwriting Agreement (Filed With SEC on August 16, 2022)
Senior Secured Convertible Promissory Note, dated as of April 11, 2022, issued by the Company in favor of Puritan Partners LLC (Filed With SEC on April 26, 2022)
Securities Purchase Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC (Filed With SEC on April 26, 2022)
Intellectual Property Security Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC (Filed With SEC on April 26, 2022)
Security Agreement, dated April 11, 2022, between the Company and Puritan Partners LLC (Filed With SEC on April 26, 2022)
Form of Warrant (Annex C to the Form of Warrant Agent Agreement attached as Exhibit 4.2) (Filed With SEC on January 5, 2022)
Form of Underwriting Agreement (Filed With SEC on January 5, 2022)
Debt Forgiveness and Exchange Agreement, dated as of December 1, 2021, between the Company and Aquanova AG (Filed With SEC on December 17, 2021)
Agreement between the Company and Syneos Health (Filed With SEC on November 9, 2021)
Amendment to Services Agreement between the Company and Technical Resources International, Inc (Filed With SEC on November 9, 2021)
Services Agreement between the Company and Technical Resources International, Inc (Filed With SEC on November 9, 2021)
Material Transfer Agreement between the Company and University of Miami (Filed With SEC on November 9, 2021)
Manufacturing Agreement between Company and Catalent (Filed With SEC on November 9, 2021)
Grant Agreement between Company and National Institute on Aging (Filed With SEC on November 9, 2021)
Agreement between Company and Murdoch Childrens Research Institute (Filed With SEC on November 9, 2021)
Employment Agreement, dated as of September 1, 2021, between the Company and Alison Silva (Filed With SEC on October 12, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Christer Rosn (Filed With SEC on October 12, 2021)
Employment Agreement, dated as of September 1, 2021, between the Company and Marshall Hayward, Ph.D (Filed With SEC on October 12, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Marshall Hayward, Ph.D (Filed With SEC on October 12, 2021)
Employment Agreement, dated as of June 6, 2021, between the Company and Alexander Rosn (Filed With SEC on October 12, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Alexander Rosn (Filed With SEC on October 12, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Dana Eschenburg Perez (Filed With SEC on October 12, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 29, 2021, between the Company and Alison D. Silva (Filed With SEC on October 12, 2021)
Employment Agreement, dated as of June 1, 2021, between the Company and Dana Eschenburg Perez (Filed With SEC on October 12, 2021)
Independent Director Agreement, dated as of September 8, 2021, between the Company and Nicholas H. Hemmerly (Filed With SEC on October 12, 2021)
Independent Director Agreement, dated as of September 8, 2021, between the Company and Julie Kampf (Filed With SEC on October 12, 2021)
Independent Director Agreement, dated as of September 8, 2021 between the Company and Alison W. Brady (Filed With SEC on October 12, 2021)
Independent Director Agreement, dated as of September 8, 2021, between the Company and John Ditton (Filed With SEC on October 12, 2021)
Independent Director Agreement, dated as of September 8, 2021, between the Company and Holger Weis (Filed With SEC on October 12, 2021)
Jupiter Orphan Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on October 12, 2021)